APRIL - 20235TECH OUTLOOKIN MY OPINIONLAST WORD30C O NT E NT SCarlos Pedraza, PhD, Director of CNS Biology, AlkermesThe Cancer Immunotherapy Treatment ParadigmCharles Drake, M.D., Ph.D., Vice President, Immuno-Oncology, The Janssen Pharmaceutical Companies of Johnson & Johnson [NYSE:JNJ]08Innovation vs Validation in Early Drug DiscoveryActinium PharmaceuticalsSandesh Seth, Chairman & CEO20MedOnect, Inc.Dr. Ziad George, Executive Director16KaliVir ImmunotherapeuticsStephen Thorne, Co-Founder and CSO24Teon TherapeuticsLina Yao, Founder and CSO27TOP 10IMMUNOTHERAPYSOLUTIONS PROVIDERS - 2023Coastar TherapeuticsHan Liang Lim, CEO22Eddie Chung, CSO
< Page 4 | Page 6 >